Skip to main content

Table 2 Cycle outcome characteristics for Cohorts I, II and III in age categories

From: Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH

Ages (years)

<36

36–38

39–40

41–42

≥43

COHORT I (n = 1247)

 Cycles (n)

432

174

162

183

296

 Embryos (n)

7.5 ± 5.1

3.7 ± 2.9

3.7 ± 2.9

3.3 ± 2.4

3.1 ± 2.2

 Pregnancies

  n

203

49

40

32

22

  %

47.0

28.2

24.7

17.5

7.4

 Live births

  n

173

34

29

18

10

  %

40.0

19.5

17.9

9.8

3.4

 Miscarriages

  n

30

15

11

14

12

  %

14.8

30.6

27.8

43.8

54.6

COHORT II (n = 1514)

 Cycles (n)

303

234

239

259

479

 FSH (mIU/mL)

11.8 ± 12.7

15.0 ± 14.1

15.5 ± 13.2

14.7 ± 14.2

18.0 ± 16.9

 Pregnancies

  n

101

50

40

32

23

  %

33.3

21.4

16.7

12.4

4.8

 Live births

  n

86

35

29

18

10

  %

28.4

15.0

12.1

6.9

2.1

 Miscarriages

  n

15

15

11

14

13

  %

14.9

30.0

27.5

43.8

56.5

COHORT III (n = 632)

 Cycles (n)

127

87

103

109

206

 AMH (ng/mL)

2.3 ± 3.3

1.1 ± 1.9

0.7 ± 1.0

0.6 ± 1.1

0.7 ± 0.7

 Pregnancies

  n

45

16

16

14

15

  %

35.4

18.4

15.5

12.8

7.3

 Live births

  n

37

11

13

7

5

  %

29.1

12.6

12.6

6.4

2.4

 Miscarriages

  n

8

5

3

7

10

  %

17.8

31.2

18.8

50.0

66.7